Bishnu Debasree, Santra Suman, Dhali Gopal Krishna, Chowdhury Abhijit, Santra Amal
Trop Gastroenterol. 2016 Jan-Mar;37(1):27-36. doi: 10.7869/tg.316.
Anti tuberculosis therapy agent isoniazid (INH) and rifampicin (RMP) injure hepatocytes. Heme oxygenase-1(HO-1) is a stress induced protein which seems to have some cellular protective function. We examined the protective function of HO-1 during INH-RMP induced cell death of hepatocytes by induction of HO-1 using hemin chloride or by silencing HO-1 gene using small interfering RNA (siRNA).
The role of HO-1 induction on INH-RMP induced cell death was examined on HepG2 cells overexpressing human CYP2E1 gene (E47 cells) during short term culture. The E47 cells were treated with hemin chloride to induce HO-1 expression during INH-RMP treatment. In other set of experiments, transient knockdown of HO-1 gene using siRNA was carried out before treatment of INH-RMP. Cell viability using Trypan blue, intracellular reactive oxygen species (ROS), cell death were evaluated by FACS analysis at different time points of INH-RMP treatment.
INH-RMP treatment to E47 cells induced expression of cytoplasmic HO-1 protein at early hours of drug treatment with minimum loss of cell viability and cell death. At later hours, failiure to express HO-1 protein resulted in loss of cell viability and increased cell death. Addition of Hemin chloride during treatment of INH-RMP induced HO-1 in E47 cells and reversed the drug induced liver injury. Silencing the HO-1 gene using siRNA potentiated INH-RMP induced cell death of the E47 cells
Induction of HO-1 ameliorated INH-RMP induced cell death of hepatocytes. This may be a potential target for future therapeutic option in INH-RMP induced drug induced liver injury.
抗结核治疗药物异烟肼(INH)和利福平(RMP)会损伤肝细胞。血红素加氧酶-1(HO-1)是一种应激诱导蛋白,似乎具有一定的细胞保护功能。我们通过使用氯化血红素诱导HO-1或使用小干扰RNA(siRNA)沉默HO-1基因,研究了HO-1在INH-RMP诱导的肝细胞死亡过程中的保护作用。
在短期培养过程中,研究HO-1诱导对过表达人CYP2E1基因的HepG2细胞(E47细胞)中INH-RMP诱导的细胞死亡的作用。在INH-RMP处理期间,用氯化血红素处理E47细胞以诱导HO-1表达。在另一组实验中,在INH-RMP处理之前,使用siRNA瞬时敲低HO-1基因。在INH-RMP处理的不同时间点,通过台盼蓝检测细胞活力,通过流式细胞术分析评估细胞内活性氧(ROS)和细胞死亡情况。
用INH-RMP处理E47细胞,在药物处理早期诱导细胞质HO-1蛋白表达,细胞活力和细胞死亡损失最小。在后期,未能表达HO-1蛋白导致细胞活力丧失和细胞死亡增加。在INH-RMP处理期间添加氯化血红素可诱导E47细胞中的HO-1,并逆转药物诱导的肝损伤。使用siRNA沉默HO-1基因可增强INH-RMP诱导的E47细胞死亡。
HO-1的诱导改善了INH-RMP诱导的肝细胞死亡。这可能是未来治疗INH-RMP诱导的药物性肝损伤的潜在治疗靶点。